Issue Date: February 17, 2014
Biotech Stock Offerings Boom
Starting 2014 with a bang, biotech companies have moved quickly to raise capital. Just six weeks into the year, 16 small drug firms have launched initial public offerings (IPOs) that together should raise more than $1 billion. Although the pace is well ahead of what was seen in 2012 and 2013, it may be hard to maintain.
The roughly dozen offerings that debuted between late January and early February this year are more than twice . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society